Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MABp1 in Hidradenitis Suppurativa
NCT02643654Phase 2Completed
- Start
- Dec 2015
- Primary completion
- Oct 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bermekimab in hidradenitis suppurativa (HS). Started Dec 2015; status: completed.
02
Drugs
bermekimab
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT02643654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643654.